A Study of PTS for Patients With Solid Tumors

NCT03448211 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Development strategy reasons

Conditions

Solid Tumor

Interventions

DRUG: Para-toluenesulfonamide Injection (PTS)

Sponsor

PTS International Inc.